Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Proof of Concept in the Prevention of Post-bariatric Sarcopenia: Simulated Activation of the "Gravitostat" [NA]

View source ↗

Summary

A proof-of-concept trial investigates simulated gravitostat activation to prevent post-bariatric sarcopenia. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Obesity &Amp; Overweight, Bariatric Surgery | NA | Status: NOT_YET_RECRUITING